Jennifer Nyitray, PA
Physician Assistant · Saint Marys, OHNPI 1740250968
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (50.7%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 37 manufacturers reported payments, led by Jazz Pharmaceuticals Inc. at 45.8% of the total. Reporting peaked in 2024 at $6,141 and has fallen 50.1% since, to $3,065 in 2025. Among physician assistant clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 378 payments — averaging $35.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$6K
- Inspire Medical Systems, Inc.$2K
- Harmony Biosciences LLC$907
- AstraZeneca$762
- Axsome Therapeutics, Inc.$645
- Avadel CNS Pharmaceuticals, LLC$573
- plus $2K from 31 others
What the payments were for
- Consulting fees$1501%
- Speaking & faculty fees$2,92822%
- Travel & lodging$2,91122%
- Food & beverage$6,81251%
- Education$6225%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,423 in reported general payments places this provider in the 95th percentile of 4,098 physician assistant providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NucalaMepolizumab | 13 | $43,735 |
| SunosiSolriamfetol Hcl | 30 | $35,149 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 17 | $9,621 |
| Armodafinil | 42 | $7,907 |
| Modafinil | 52 | $7,756 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 11 | $5,113 |
| Ropinirole Hcl | 98 | $1,368 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 15 | $1,265 |
| Gabapentin | 99 | $1,169 |
| Doxepin Hcl | 52 | $974 |
| Quetiapine Fumarate | 71 | $789 |
| Trazodone Hcl | 137 | $737 |
| Clonazepam | 131 | $667 |
| Methylphenidate Hcl | 12 | $610 |
| Mirtazapine | 42 | $516 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKNucala, Trelegy Ellipta | $217 | $53,35630 claims |
| Axsome Therapeutics, Inc.Sunosi | $645 | $35,14930 claims |
| Boehringer IngelheimStiolto Respimat | $159 | $5,11311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,098 physician assistant providers in Ohio.
Other physician assistant in Saint Marys
- Steven WurzelbacherCincinnati$309K
- Emily AnkromDayton$192K
- Amanda MaggartWorthington$164K
- Megan SevillaMayfield Heights$132K
- Erin StrculaBelpre$106K
- Sarah LaubNew Albany$100K
- Jessica RhominskiCanal Winchester$78K
- Brook GramBeloit$52K
- Alison FleigToledo$48K
- Alicia PerkinsColumbus$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.